<DOC>
	<DOCNO>NCT02935010</DOCNO>
	<brief_summary>With markedly increase antibiotic resistance unsatisfactory efficacy common empiric eradication regimen mainland China , tailor therapy may best choice achieve good efficacy . This study compare eradication rate , safety , compliance antibiotic sensitivity-based tailor therapy compare empiric bismuth quadruple therapy naive patient Helicobacter pylori infection .</brief_summary>
	<brief_title>Tailored Versus Empiric Therapy Helicobacter Pylori Treatment</brief_title>
	<detailed_description />
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Potassium Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Participants nonulcer functional dyspepsia scar peptic ulcer disease Ability willingness participate study sign give inform consent confirm H. pylorus infection Previous H. pylorus eradication therapy Less 18 year old With history H. pylori infection treatment With previous gastric surgery Major systemic disease Pregnancy lactation Allergy study drug Administration antibiotic , bismuth , antisecretory drug 8 week prior inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Bismuth quadruple therapy</keyword>
	<keyword>Tailored therapy</keyword>
	<keyword>Empiric therapy</keyword>
	<keyword>clarithromycin susceptibility</keyword>
</DOC>